Sir,
A 40-year-old male who presented with chronic kidney disease secondary to diabetic nephropathy underwent renal transplant surgery with his spouse as donor. Induction therapy was given with injection basiliximab (20 mg -two doses) and immunosuppression with tacrolimus (3 mg twice a day), prednisolone (20 mg), and mycophenolate mofetil (1.5 g).
After 3 months, he presented with complaints of abdominal pain, vomiting, and decreased appetite of two weeks duration. Biochemical analysis revealed serum creatinine 0.8 mg/dl, hemoglobin of 9 g/dl; total leukocyte count of 9500/µl with normal differential and platelet count. Blood and urine cultures were sterile. Blood cytomegalovirus polymerase chain reaction was negative.
Roentgenogram of the abdomen revealed distended bowel loops. Esophageal endoscopy done for odynophagia revealed ulcerations in the esophagus. Small pin head-sized white patches in the duodenum were biopsied and they revealed Schistosomal larvae and adult forms [ Figure 1 ]. Wet mount of stool demonstrated Strongyloides larvae. He developed breathlessness in the 2 nd week of hospital stay. Roentenogram of the chest showed right lower lobe infiltrates. Fiber-optic bronchoscopy revealed fresh blood in both main bronchi with normal mucosa. Bronchoalveolar lavage (BAL) showed motile Strongyloides larvae with Gram's stain positive for Candida. BAL culture grew Klebsiella. He was treated with tablet ivermectin (200 mcg/kg/day) and tablet albendazole (800 mg/day) along with injection meropenem (1 g thrice a day) and liposomal amphotericin
Strongyloid Hyperinfection Syndrome in a Renal Transplant Recipient
Letters to Editor B to cover secondary infections. Chest roentgenogram in the 3 rd week revealed clearing of infiltrates. Antifungal and antibacterial treatment was given for a total of 2 weeks. The patient was discharged in a stable condition. Anti-parasitic drugs were continued for 12 weeks. He is on follow-up with normal graft function (serum creatinine 1.0 mg/dl) and good general condition. Stool examination was negative for larvae at 4 weeks of treatment and it was reconfirmed at 12 weeks.
The prevalence of Strongyloides in India is 12.7%. [1] Strongyloides stercoralis is an intestinal nematode. The unique feature is its ability to continue life cycle in humans itself (autoinfection) [2] . Transplant recipients are at risk for developing Strongyloides hyperinfection syndrome due to immunosuppression. It is frequently complicated by infections with Gram-negative bacilli which migrate from bowel. [3] Prevention is the best modality to reduce incidence of this disease. Routine preoperative screening in case of solid organ transplantation is advised either by ELISA (IgG) method or stool examination. Chronic infection should be treated before transplant to decrease high risk of relapses once immunosuppression is started. [4] [5] [6] Diagnosis of this condition can be made by stool examination on wet mount, stool culture, serology, biopsy of duodenal mucosa or skin lesions, or wet mount of body fluids. [7] Ivermectin is the treatment of choice in a dose of 200 µg/kg. In chronic infection, the drug is given in two doses, followed by a third dose after 2 weeks. Immunosuppressed patients are prescribed longer courses till negative samples are obtained. 
Streptococcus gallolyticus subsp. pasteurianus Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis
Sir, We report the first case of Streptococcus gallolyticus subsp. pasteurianus peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD). A 63-year-old male of Indian origin, on CAPD since April 2013, presented to us with CAPD peritonitis. He was admitted and initiated on intraperitoneal (IP) cloxacillin and ceftazidime as per International Society of Peritoneal Dialysis guidelines. His laboratory investigations were as follows: C-reactive protein 47 mg/L, total white cell count 4.3 × 10 9 /L, peritoneal dialysate (PD) cell count was 200 cells/mm 3 with predominant polymorphs. Dialysate fluid cleared up on day 2 of treatment with subsequent cell count of 25 cells/mm 3 , and corresponding negative cell counts repeated twice. Preliminary reports revealed Gram-positive cocci in the dialysate fluid; therefore, IP ceftazidime was discontinued and IP cloxacillin maintained. However, on day 4 of treatment, PD culture grew S. gallolyticus subsp. pasteurianus, which was resistant to clindamycin, erythromycin, trimethoprim/ sulfamethoxazole, and tetracycline but sensitive to cephalexin and penicillin G. IP cloxacillin was then changed to IP penicillin G 50,000 U per 2 L dialysate bag. He remained asymptomatic and was discharged, to complete 2 weeks of IP penicillin G on an outpatient basis.
Streptococcus has over 50 species in its genus. A serotype classification called Lancefield grouping was used to further classify beta-hemolytic streptococci based on specific carbohydrates present on the bacterial cell wall. S. gallolyticus subsp. pasteurianus is a newly classified group D Streptococcus species previously known as Streptococcus bovis type II/2. S. bovis has 2 biotypes: I and II. This new classification is due to their unique ability to be able to decarboxylate gallic acid. [1] Its unique genetic diversity has resulted in many subspecies that have been associated with an array of clinical implications. [2] They frequently inhabit the gastrointestinal tract of human and animals such as horses, cattle, pigs, and sheep. Besides its association with endocarditis and colorectal carcinoma, S. gallolyticus subsp. pasteurianus has been linked as a causative agent for meningitis and septicemia in patients with colonic carcinoma, cirrhosis, and chronic liver disease. [3, 4] Immunocompromised patients have been known to succumb fatally to septicemia caused by S. gallolyticus subsp. pasteurianus. [5] Our timely initiation of IP ceftazidime and cloxacillin and prompt revision of antibiotics therapy according to antibiogram on day 4 with IP penicillin G led to the successful treatment of peritonitis. Our experience and literature review suggests that S. gallolyticus subsp. pasteurianus infection must not be taken lightly. Awareness regarding the threat posed by this organism is important to ensure the prompt initiation of antimicrobial therapy.
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